Metoprolol Succinate
Brand names: Metoprolol Succinate, Kapspargo Sprinkle, Toprol Xl
At a glance
- Medicare prescriptions, 2024
- 30,941,746
- Medicare drug cost
- $440.9M
- Average cost per prescription
- $14.25
- Clinicians who prescribed it
- 282,123
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
Metoprolol succinate extended-release tablets are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. Angina Pectoris. Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure.
From the FDA-approved prescribing information (label dated August 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Family Medicine 24.4%
- Internal Medicine 21.8%
- Cardiology 17.4%
- Nurse Practitioners 16.7%
- Physician Assistants 5.8%
- Interventional Cardiology 5.8%
- Cardiac Electrophysiology 2.0%
- General Practice 1.3%
- Geriatric Medicine 1.2%
- Nephrology (Kidney) 0.8%
- Hospitalist 0.6%
- Heart Failure & Transplant Cardiology 0.5%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 32% from 2019 to 2024.
Biggest change by state since 2019
- Utah +53%
- Idaho +52%
- Oklahoma +50%
- Tennessee +49%
- Florida +49%
- New Mexico (smallest change) +13%
- Massachusetts (smallest change) +17%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 4 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
Cardinal Health 107, LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 25 mg | white oval tablet, 10 mm, scored to split in 2 | M 1 |
Pd-Rx Pharmaceuticals, Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 50 mg | white round tablet, 8 mm, scored to split in 2 | E71 |
Redpharm Drug
| Strength | Looks like | Imprint |
|---|---|---|
| 25 mg | white oval tablet, 10 mm, scored to split in 2 | M 1 |
Remedyrepack Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 25 mg | white oval tablet, 8 mm, scored to split in 2 | I 25 |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
Drug makers reported $486 in payments to clinicians that named this drug in 2025 (meals, speaking, consulting and similar).
- Sun Pharmaceutical Industries Inc. $486
Source: CMS Open Payments, general payments (not research), program year 2025. A payment is not evidence of wrongdoing. Payments by doctor
Recalls and shortages
Not on the FDA drug shortage list.
4 recalls since 2020
- Jan 2026 · Teva Pharmaceuticals USA, Inc · Class II
Failed Dissolution Specifications - Jan 2023 · Amerisource Health Services LLC · Class II
Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories. - Jan 2022 · Cardinal Healthcare · Class II
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. - Dec 2021 · American Health PAckaging · Class II
Failed Dissolution Specifications
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.